Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis
Summary Background Hepatitis C virus ( HCV ) clearance with IFN ‐based therapies reduces the incidence of hepatocellular carcinoma ( HCC ). There has been some debate if IFN ‐free therapy with direct‐acting antivirals alters the risk for HCC . Aim To investigate the HCC incidence in cirrhotic HCV pa...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | 英語 |
| 出版事項: |
2017
|
| オンライン･アクセス: | https://doi.org/10.1111/apt.14427 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14427 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|